Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. We will update and add to this page on a regular basis. This page is not a compilation of all relevant information but rather contains some key highlights that we consider to be of importance to share with the community.
Sign-Up for our newsletter and never miss out on the latest news and updates.
Check out our News Portal with real-time listing of news and articles in genomics, genetics, precision medicine, and beyond.
News for the month January 2026
Funding / IPO
- **OpenEvidence clinches $250M series D as AI platform sees explosive growth with doctors
- 2025 year-end digital health funding overview: A tale of two markets A Rock Health report
- Xella Health Raises $3.7 Million Pre-Seed to Launch Women’s Precision Health Platform
- Carna Health Secures $8 Million to Expand Access to Scalable Chronic Kidney Disease Screening Solutions Globally Funding to accelerate innovation and growth following strategic partnership with Siemens Healthineers
- RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
- Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings
- Protege Raises $30M Led by a16z to Unlock Access to Data for AI Development The company provides licensed, curated access to real-world and proprietary datasets across domains such as media, audio, and healthcare, supporting AI training and evaluation for major global AI companies.
- bit.bio secures $50 million Series C to scale human cell programming technology
Mergers & Acquisitions
- JPM26
- Novartis pays $50M for China biotech’s cancer therapy asset
- Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B
- Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
- Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale
- Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale
- **OpenAI acquires health-care technology startup Torch for $60 million
- Hippocratic AI acquires Grove AI, taps life sciences leaders to focus on biopharma, medtech
- **bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies This strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide
Precision Medicine
(Omics) Data Platform / Sequencing / Analysis / Instruments
Diagnostics / Genomic / Genetic Testing / CDx
- **10x Genomics to Advance REsearch in Diagnostics Applications of Tumor Single Cell Profiling 10x announced clinical collaborations with two Boston-based institutions, Brigham & Women’s Hospital and Dana-Farber Cancer Institute, as well as the New York-based Cancer Research Institute. The company also committed to building its own CLIA-certified laboratory within about a year, with the goal of enabling clinical deployment of diagnostics that will come up with these kinds of collaborations.
AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI
- JPM26
- **Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
- **Anthropic joins OpenAI’s push into health care with new Claude tools Anthropic’s new offerings allow users and providers to work with medical data, mimicking similar moves by OpenAI.
- **OpenAI launches ChatGPT Health in a push to become a hub for personal health data
- FDA clears Aidoc tool to detect 14 different conditions from a CT scan It’s one of the first instances of the agency clearing an AI tool that looks for multiple conditions
- Amazon launches AI health-care tool for One Medical members
- Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere
- Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
- Exclusive: 40 million people turn to ChatGPT for health care
Miscellaneous
- Walmart dips its toe back into healthcare with new digital platform
- Trump releases health care plan amid pressure over affordability President’s plan is light on details, but could shape debate in Congress
- Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill
- FDA announces sweeping changes to oversight of wearables, AI-enabled devices The changes could allow unregulated generative artificial intelligence tools into clinical workflows
- **Illumina Appoints Dr. Eric Green as Chief Medical Officer
Publications
- De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa
- **A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma Researches developed an Immune Atlas of MM by generating profiles of 1,397,272 single cells from the bone marrow (BM) of 337 newly diagnosed participants and characterized immune and hematopoietic cell populations
